Back to search

Alteration of p53 damage response by tamoxifen treatment.

Data up to Jan 2025

Published1996
Citations17
References23

Total Citations Per Year

Abstract

References (23)

p53 is required for radiation-induced apoptosis in mouse thymocytes

1993 • 2,911 citations

Thymocyte apoptosis induced by p53-dependent and independent pathways

1993 • 2,322 citations

Wild-type p53 is a cell cycle checkpoint determinant following irradiation.

1992 • 1,877 citations

p53 Status and the Efficacy of Cancer Therapy in Vivo

1994 • 1,483 citations

Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines.

1990 • 607 citations

Risk of endometrial cancer after tamoxifen treatment of breast cancer

1994 • 574 citations

p53 mutations increase resistance to ionizing radiation.

1993 • 573 citations

Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells.

1995 • 422 citations

Development of antiestrogens and their use in breast cancer: eighth Cain memorial award lecture.

1990 • 419 citations

p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.

1994 • 410 citations

Tamoxifen and metabolites in MCF7 cells: correlation between binding to estrogen receptor and inhibition of cell growth.

1982 • 393 citations

Cell cycle arrests and radiosensitivity of human tumor cell lines: dependence on wild-type p53 for radiosensitivity.

1994 • 333 citations

Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents.

1996 • 298 citations

Effects of tamoxifen on human breast cancer cell cycle kinetics: accumulation of cells in early G1 phase.

1983 • 275 citations

Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7.

1995 • 272 citations

Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.

1995 • 179 citations

To pop or not to pop: p53 as a critical modulator of tumour responsiveness to therapy in vivo?

1995 • 168 citations

Lack of genotoxicity of tamoxifen in human endometrium.

1996 • 129 citations

Effects of antioestrogens on the proliferation of MCF-7 human breast cancer cells

1989 • 110 citations

Hormonal Regulation of the p53 Tumor Suppressor Protein in T47D Human Breast Carcinoma Cell Line

1995 • 80 citations

A functional screen for germ line p53 mutations based on transcriptional activation.

1992 • 66 citations

Protein synthesis—dependent cytoplasmic translocation of p53 protein after serum stimulation of growth‐arrested MCF‐7 cells

1993 • 39 citations

p53 as a growth suppressor gene in HBV-related hepatocellular carcinoma cells.

1993 • 32 citations

Cited By (0)

No citing papers found in database

Alteration of p53 damage response by tamoxifen treatment. (1996) – PubMed | Metascience Observatory Explorer